FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2215396324> ?p ?o ?g. }

• W2215396324 abstract "Abstract Introduction Recently, the critical roles of CD47 on the surface of resistant cancer cells and its ligand, signal regulatory protein alpha (SIRPα), have been proposed in their evasion of immunosurveillance. Primary effusion lymphoma (PEL) is a subtype of aggressive non-Hodgkin lymphoma that shows serous lymphomatous effusion without tumor masses in body cavities especially in advanced advanced acquired immunodeficiency syndrome (AIDS). The lack of optimal therapy combined with the aggressive nature of PEL results in a short median survival of less than 6 months. There is therefore a need for the development of new therapies. In this study, we transplanted PEL cells intraperitoneally into immunodeficient mice and evaluated the effect of targeting CD47-SIRPα signal with anti-CD47 antibody (Ab) and NOD-specific SIRPα on PEL. Methods Surface CD47 expressions of six PEL cell lines and peripheral blood mononuclear cells (PBMC) from six different donors were examined by flow cytometry. The antiproliferative activities of anti-CD47Ab against PEL cell lines were measured by the methylthiotetrazole (MTT) method. Efficacy of anti-CD47 Ab-mediated phagocytosis against PEL was evaluated using mouse peritoneal macrophages and human macrophages in vitro. In a direct xenograft mouse model, primary PEL cells were injected intraperitoneally into NOD/Rag-2/Jak3 double-deficient mice to assess the in vivo efficacy of anti-CD47 Ab. To clarify the effect of NOD-specific SIRPα on PEL, we compared the phagocytic activities of peritoneal macrophages against PEL and the in vivo engraftment of PEL among Rag-2/Jak3 double-deficient mice with NOD and non-NOD (Balb/c and C57/BL6) genetic backgrounds. Organ invasion by PEL cells was evaluated by immunohistochemistry and flow cytometry. Results Surface CD47 of PEL cell lines was highly expressed compared with that of PBMC. Anti-CD47 Ab did not have a direct antitumor effect against PEL cell lines. Treatment with anti-CD47 Ab promoted phagocytic activities of mouse peritoneal macrophages and human macrophages in vitro. In addition, the expression of CD47 was significantly correlated with the fold increase of phagocytic activity. Treatment with anti-CD47 Ab inhibited the ascites formation and organ invasion completely in vivo compared with control IgG-treated mice. Anti-CD47 Ab-treated mice seemed to stay in healthy and show no apparent change. Although the numbers of peritoneal macrophages were not different among Rag-2/Jak3 double-deficient mice with NOD and non-NOD genetic backgrounds, the phagocytic activity in NOD mice was significantly decreased compared with non-NOD mice. Consistent with the data of phagocytosis assay, the development of PEL cells in NOD mice was superior to those in non-NOD mice. Conclusions CD47 and SIRPα play the pivotal role in the immune evasion of PEL. NOD-specific SIRPα polymorphism has been reported to produce signals for macrophages not to engulf human cells. Thus, NOD-specific SIRPα is considered to contribute to the attenuation of macrophage phagocytosis and enable the development of PEL. CD47-SIRPα signal could be a therapeutic target for the immunotherapy of PEL. Disclosures: No relevant conflicts of interest to declare." @default.
• W2215396324 created "2016-06-24" @default.
• W2215396324 creator A5004262871 @default.
• W2215396324 creator A5020073373 @default.
• W2215396324 creator A5040927651 @default.
• W2215396324 creator A5069728941 @default.
• W2215396324 creator A5072197843 @default.
• W2215396324 creator A5084560457 @default.
• W2215396324 date "2013-11-15" @default.
• W2215396324 modified "2023-09-27" @default.
• W2215396324 title "Evaluation Of Targeting CD47-SIRPα Using Primary Effusion Lymphoma Xenograft Mouse Model" @default.
• W2215396324 doi "https://doi.org/10.1182/blood.v122.21.1827.1827" @default.
• W2215396324 hasPublicationYear "2013" @default.
• W2215396324 type Work @default.
• W2215396324 sameAs 2215396324 @default.
• W2215396324 citedByCount "0" @default.
• W2215396324 crossrefType "journal-article" @default.
• W2215396324 hasAuthorship W2215396324A5004262871 @default.
• W2215396324 hasAuthorship W2215396324A5020073373 @default.
• W2215396324 hasAuthorship W2215396324A5040927651 @default.
• W2215396324 hasAuthorship W2215396324A5069728941 @default.
• W2215396324 hasAuthorship W2215396324A5072197843 @default.
• W2215396324 hasAuthorship W2215396324A5084560457 @default.
• W2215396324 hasConcept C137061746 @default.
• W2215396324 hasConcept C150903083 @default.
• W2215396324 hasConcept C159654299 @default.
• W2215396324 hasConcept C202751555 @default.
• W2215396324 hasConcept C203014093 @default.
• W2215396324 hasConcept C207001950 @default.
• W2215396324 hasConcept C2776885095 @default.
• W2215396324 hasConcept C2779338263 @default.
• W2215396324 hasConcept C2779468541 @default.
• W2215396324 hasConcept C2779594685 @default.
• W2215396324 hasConcept C2780104668 @default.
• W2215396324 hasConcept C40677261 @default.
• W2215396324 hasConcept C502942594 @default.
• W2215396324 hasConcept C542903549 @default.
• W2215396324 hasConcept C55493867 @default.
• W2215396324 hasConcept C55851684 @default.
• W2215396324 hasConcept C71924100 @default.
• W2215396324 hasConcept C86803240 @default.
• W2215396324 hasConcept C8891405 @default.
• W2215396324 hasConceptScore W2215396324C137061746 @default.
• W2215396324 hasConceptScore W2215396324C150903083 @default.
• W2215396324 hasConceptScore W2215396324C159654299 @default.
• W2215396324 hasConceptScore W2215396324C202751555 @default.
• W2215396324 hasConceptScore W2215396324C203014093 @default.
• W2215396324 hasConceptScore W2215396324C207001950 @default.
• W2215396324 hasConceptScore W2215396324C2776885095 @default.
• W2215396324 hasConceptScore W2215396324C2779338263 @default.
• W2215396324 hasConceptScore W2215396324C2779468541 @default.
• W2215396324 hasConceptScore W2215396324C2779594685 @default.
• W2215396324 hasConceptScore W2215396324C2780104668 @default.
• W2215396324 hasConceptScore W2215396324C40677261 @default.
• W2215396324 hasConceptScore W2215396324C502942594 @default.
• W2215396324 hasConceptScore W2215396324C542903549 @default.
• W2215396324 hasConceptScore W2215396324C55493867 @default.
• W2215396324 hasConceptScore W2215396324C55851684 @default.
• W2215396324 hasConceptScore W2215396324C71924100 @default.
• W2215396324 hasConceptScore W2215396324C86803240 @default.
• W2215396324 hasConceptScore W2215396324C8891405 @default.
• W2215396324 hasLocation W22153963241 @default.
• W2215396324 hasOpenAccess W2215396324 @default.
• W2215396324 hasPrimaryLocation W22153963241 @default.
• W2215396324 hasRelatedWork W1481665025 @default.
• W2215396324 hasRelatedWork W1497691292 @default.
• W2215396324 hasRelatedWork W1564959198 @default.
• W2215396324 hasRelatedWork W1642928709 @default.
• W2215396324 hasRelatedWork W1983403875 @default.
• W2215396324 hasRelatedWork W1984829276 @default.
• W2215396324 hasRelatedWork W2001297846 @default.
• W2215396324 hasRelatedWork W2061077151 @default.
• W2215396324 hasRelatedWork W2087107153 @default.
• W2215396324 hasRelatedWork W2089260704 @default.
• W2215396324 hasRelatedWork W2119913460 @default.
• W2215396324 hasRelatedWork W2128390153 @default.
• W2215396324 hasRelatedWork W2129714647 @default.
• W2215396324 hasRelatedWork W2155959680 @default.
• W2215396324 hasRelatedWork W2249649723 @default.
• W2215396324 hasRelatedWork W2556167380 @default.
• W2215396324 hasRelatedWork W2563110772 @default.
• W2215396324 hasRelatedWork W2588629939 @default.
• W2215396324 hasRelatedWork W2972279356 @default.
• W2215396324 hasRelatedWork W3193360638 @default.
• W2215396324 isParatext "false" @default.
• W2215396324 isRetracted "false" @default.
• W2215396324 magId "2215396324" @default.
• W2215396324 workType "article" @default.